First Manhattan

First Manhattan’s Larimar Therapeutics LRMR Stock Holding History

First Manhattan’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,000	Closed	-$39K	–	1638
2021 Q2	$39K	Sell	4,000 -7,000	-64%	-$79.1K	﹤0.01%	1035
2021 Q1	$160K	Hold	11,000	–	–	﹤0.01%	746
2020 Q4	$235K	Hold	11,000	–	–	﹤0.01%	641
2020 Q3	$166K	Hold	11,000	–	–	﹤0.01%	684
2020 Q2	$141K	Buy	+11,000	New	+$128K	﹤0.01%	707
2019 Q1	–	Sell	-466	Closed	-$27K	–	1433
2018 Q4	$27K	Buy	+466	New	+$46K	﹤0.01%	1029

Other funds holding LRMR

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return